The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature

被引:110
作者
Anglin, Rebecca E. [1 ]
Garside, Sarah L. [1 ]
Tarnopolsky, Mark A. [2 ]
Mazurek, Michael F. [3 ]
Rosebush, Patricia I. [1 ]
机构
[1] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
[2] McMaster Univ, Dept Pediat, Hamilton, ON, Canada
[3] McMaster Univ, Dept Neurol, Hamilton, ON, Canada
关键词
STROKE-LIKE EPISODES; TRANSFER RNA(LEU(UUR)) MUTATION; KEARNS-SAYRE SYNDROME; LACTIC-ACIDOSIS; EXTERNAL OPHTHALMOPLEGIA; ENCEPHALOMYOPATHY MELAS; DEPRESSIVE DISORDER; MULTIPLE DELETIONS; DIABETES-MELLITUS; MAJOR DEPRESSION;
D O I
10.4088/JCP.11r07237
中图分类号
B849 [应用心理学];
学科分类号
040203 [应用心理学];
摘要
Objective: Mitochondrial disorders are caused by gene mutations in mitochondrial or nuclear DNA and affect energy-dependent organs such as the brain. Patients with psychiatric illness, particularly those with medical comorbidities, may have primary mitochondrial disorders. To date, this issue has received little attention in the literature, and mitochondrial disorders are likely underdiagnosed in psychiatric patients. Data Sources: This article describes a patient who presented with borderline personality disorder and treatment-resistant depression and was ultimately diagnosed with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) 3271. We also searched the literature for all case reports of patients with mitochondrial disorders who initially present with prominent psychiatric symptoms by using MEDLINE (from 1948-February 2011), Embase (from 1980-February 2011), PsycINFO (from 1806-February 2011), and the search terms mitochondrial disorder, mitochondria, psychiatry, mental disorders, major depression, anxiety, schizophrenia, and psychosis. Study Selection: Fifty cases of mitochondrial disorders with prominent psychiatric symptomatology were identified. Data Extraction: Information about the psychiatric presentation of the cases was extracted, This information was combined with our case, the most common psychiatric manifestations of mitochondrial disorders were identified, and the important diagnostic and treatment implications for patients with psychiatric illness were reviewed. Results:The most common psychiatric presentations in the cases of mitochondrial disorders included mood disorder, cognitive deterioration, psychosis, and anxiety. The most common diagnosis (52% of cases) was a MELAS mutation. Other genetic mitochondrial diagnoses included polymerase gamma mutations, Kearns-Sayre syndrome, mitochondrial DNA deletions, point mutations, twinkle mutations, and novel mutations. Conclusions: Patients with mitochondrial disorders can present with primary psychiatric symptomatology, including mood disorder, cognitive impairment, psychosis, and anxiety. Psychiatrists need to be aware of the clinical features that are indicative of a mitochondrial disorder, investigate patients with suggestive presentations, and be knowledgeable about the treatment implications of the diagnosis. J Clin Psychiatry 2012;73(4):506-512 (C) Copyright 2012 Physicians Postgraduate Press, Inc.
引用
收藏
页码:506 / 512
页数:7
相关论文
共 63 条
[1]
Risperidone-induced psychosis and depression in a child with a mitochondrial disorder [J].
Ahn, MS ;
Sims, KB ;
Frazier, JA .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (03) :520-525
[2]
Psychosis and progressing dementia: Presenting features of a mitochondriopathy [J].
Amemiya, S ;
Hamamoto, M ;
Goto, Y ;
Komaki, H ;
Nishino, I ;
Nonaka, I ;
Katayama, Y .
NEUROLOGY, 2000, 55 (04) :600-601
[3]
Anglin RE, 2010, PSYCHOSOMATICS, V51, P179, DOI 10.1176/appi.psy.51.2.179
[4]
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]
Deep white matter pathologic features in watershed regions - A novel pattern of central nervous system involvement in MELAS [J].
Apostolova, LG ;
White, M ;
Moore, SA ;
Davis, PH .
ARCHIVES OF NEUROLOGY, 2005, 62 (07) :1154-1156
[6]
BAN S, 1992, ACTA PATHOL JAPON, V42, P818
[7]
Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies [J].
Barragán-Campos, HM ;
Vallee, JN ;
Lô, D ;
Barrera-Ramírez, CF ;
Argote-Greene, M ;
Sánchez-Guerrero, J ;
Estañol, B ;
Guillevin, R ;
Chiras, J .
ARCHIVES OF NEUROLOGY, 2005, 62 (05) :737-742
[8]
NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517
[9]
The Mitochondrial Proteome and Human Disease [J].
Calvo, Sarah E. ;
Mootha, Vamsi K. .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 11, 2010, 11 :25-44
[10]
Mitochondrial myopathy, cardiomyopathy and psychiatric illness in a Spanish family harbouring the mtDNA 3303C > T mutation [J].
Campos, Y ;
García, A ;
Eiris, J ;
Fuster, M ;
Rubio, JC ;
Martín, MA ;
del Hoyo, P ;
Pintos, E ;
Castro-Gago, M ;
Arenas, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (06) :685-687